The Application of GHRH Antagonist as a Treatment for Resistant APL

SIMPLE SUMMARY: Previously, it has been shown that the use of growth hormone–releasing hormone (GHRH) antagonistic peptide analogs significantly suppresses the proliferation of various human cancer cell lines. However, the potential of the GHRH antagonist MIA-602 in addressing the resistance of acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Chale, Ravinder S., Almeida, Stephanie M., Rodriguez, Mario, Jozic, Ivan, Gaumond, Simonetta I., Schally, Andrew V., Jimenez, Joaquin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296252/
https://www.ncbi.nlm.nih.gov/pubmed/37370714
http://dx.doi.org/10.3390/cancers15123104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296252/
https://www.ncbi.nlm.nih.gov/pubmed/37370714
http://dx.doi.org/10.3390/cancers15123104

Ejemplares similares